المؤلفون: Cléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, Imran Lahmar, Agathe Dubuisson, Alimuddin Zumla, Didier Raoult, Mansouria Merad, Bertrand Gachot, Clémence Hénon, Eric Solary, Michaela Fontenay, Fabrice André, Markus Maeurer, Giuseppe Ippolito, Mauro Piacentini, Fu-Sheng Wang, Florent Ginhoux, Aurélien Marabelle, Guido Kroemer, Lisa Derosa, Laurence Zitvogel

المصدر: OncoImmunology, Vol 9, Iss 1 (2020)

مصطلحات موضوعية: covid-19, sars-cov-2, coronavirus, immune response, immunity, cellular, humoral, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2162-402X

URL الوصول: https://doaj.org/article/e4a221cb1a574f70b5b62f65b25271b8

المؤلفون: Florent Ginhoux, Agathe Dubuisson, Bertrand Gachot, Aymeric Silvin, Aurélien Marabelle, Imran Lahmar, Mauro Piacentini, Cléa Melenotte, Laurence Zitvogel, Guido Kroemer, Clémence Hénon, Lisa Derosa, Eric Solary, Michaela Fontenay, Didier Raoult, Fu-Sheng Wang, Markus Maeurer, Giuseppe Ippolito, Alimuddin Zumla, Mansouria Merad, Anne Gaëlle Goubet, Fabrice Andre

المساهمون: Gestionnaire, Hal Sorbonne Université, Institut Gustave Roussy (IGR), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), Immunologie intégrative des tumeurs et immunothérapie des cancers (INTIM), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre d'Investigation Clinique en Biotherapie des cancers (CIC 1428 , CBT 507 ), Institut Gustave Roussy (IGR)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), University College of London [London] (UCL), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), University Medical Center [Mainz], Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), National Institute for Infectious Diseases 'Lazzaro Spallanzani', Università degli Studi di Roma Tor Vergata [Roma], Chinese Center for Disease Control and Prevention, Shanghai Jiao Tong University [Shanghai], Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Karolinska Institutet [Stockholm], Karolinska University Hospital [Stockholm], École Pratique des Hautes Études (EPHE), ANR-16-RHUS-0008,LUMIERE,LUMIERE(2016), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP)

المصدر: OncoImmunology
OncoImmunology, 2020, 9 (1), pp.1807836. ⟨10.1080/2162402X.2020.1807836⟩
OncoImmunology, Taylor & Francis, 2020, 9 (1), pp.1807836. ⟨10.1080/2162402X.2020.1807836⟩
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)

مصطلحات موضوعية: viruses, Review, medicine.disease_cause, Diagnostic tools, Severity of Illness Index, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity, immune response, humoral, 0302 clinical medicine, Risk Factors, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Immunology and Allergy, RC254-282, Coronavirus, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Immunity, Cellular, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, virus diseases, 3. Good health, Oncology, Severe acute respiratory syndrome-related coronavirus, [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, 030220 oncology & carcinogenesis, [SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology, Middle East Respiratory Syndrome Coronavirus, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Covid-19, Coronavirus disease 2019 (COVID-19), Sars-CoV-2, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunology, 03 medical and health sciences, Immune system, Intensive care, medicine, Humans, [SDV.IMM.II] Life Sciences [q-bio]/Immunology/Innate immunity, Host Microbial Interactions, business.industry, RC581-607, Protective Factors, biochemical phenomena, metabolism, and nutrition, medicine.disease, immunity, Immunity, Humoral, Clinical trial, Middle East respiratory syndrome, Immunologic diseases. Allergy, business, cellular, 030215 immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b3330afafb3e68f7e7025c65974ed7
https://doi.org/10.1080/2162402X.2020.1807836